José Vicente González-Aramundiz (José V González-Aramundiz)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Respiratory Syndrome Coronavirus

Hyaluronic Acid

Resistance Training

Top Venues

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, Mario Calvo, Loreto Twele, Marcela González, Daniela Fuentes, Valentina Gutiérrez, Felipe Reyes, Lorena I Tapia, Rodolfo Villena, Angello Retamal-Díaz, Antonio Cárdenas, Eduardo Alarcón-Bustamante, Xing Meng, Qianqian Xin, José Vicente González-Aramundiz, María Javiera Álvarez-Figueroa, González Pa, Susan M Bueno, Jorge A Soto, null On Behalf Of The PedCoronaVac Cl Study Group, Cecilia Perret, Alexis M Kalergis
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac ® ) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile. Vaccines 11 (10) (2023)
Karla L López, Andrea Ravasio, José Vicente González-Aramundiz, Flavia C Zacconi
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) Prepared by Microwave and Ultrasound-Assisted Synthesis: Promising Green Strategies for the Nanoworld. Pharmaceutics 15 (5) (2023)
Katia Abarca, Carolina Iturriaga, Marcela Urzúa, Nicole Le Corre, Augusto Pineda, Carolina Fernández, Angélica Domínguez, González Pa, Susan M Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz-Venturelli, Carlos M Pérez, Marcela Potin, Álvaro Rojas, José Vicente González-Aramundiz, Nicolás M S Gálvez, Francisca Aguirre-Boza, Sofía Aljaro, Luis Federico Batiz, Yessica Campisto, Mariela Cepeda, Aarón Cortés, Sofía López, María Loreto Pérez, Andrea Schilling, Alexis M Kalergis, null On Behalf Of The CoronaVac Cl Study Group
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial. Vaccines 10 (7) (2022)
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, Nicolás M S Gálvez, Gaspar A Pacheco, Jorge A Soto, Roslye V Berríos-Rojas, Liliana A González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Mariana Ríos, Yaneisi Vázquez, Guillermo Hoppe-Elsholz, Omar P Vallejos, Carolina Iturriaga, Marcela Urzua, María S Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, null null, José Vicente González-Aramundiz, González Pa, Katia Abarca, Alexis M Kalergis, Susan M Bueno
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern. medRxiv : the preprint server for health sciences (2022)
Gisela F Carreño, María Javiera Alvarez-Figueroa, José Vicente González-Aramundiz
Dextran Nanocapsules with ω -3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery. Pharmaceutics 14 (11) (2022)
Rayen Yanara Valdivia-Olivares, Maria Rodriguez-Fernandez, María Javiera Álvarez-Figueroa, Alexis M Kalergis, José Vicente González-Aramundiz
The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines 9 (12) (2021)
Juan I Bussio, Carla Molina-Perea, José Vicente González-Aramundiz
Hyaluronic Acid Nanocapsules as a Platform for Needle-Free Vaccination. Pharmaceutics 11 (5) (2019)